CELLECTIS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.345 EUR | -1.47% |
|
-1.88% | -15.16% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 639.8 | 665.5 | 1,037 | 338.4 | 90.57 | 168.3 | 168.3 | - |
| Enterprise Value (EV) 1 | 238.7 | 403.7 | 905.2 | 242.2 | 52.81 | 93.73 | 149.6 | 43.6 |
| P/E ratio | -8.82 x | -7.24 x | -15.4 x | -3.22 x | -0.9 x | - | - | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 33.5 x | 32.2 x | 15.1 x | 5.57 x | 3.7 x | 7.82 x | 6.16 x | 2.08 x |
| EV / Revenue | 12.5 x | 19.5 x | 13.2 x | 3.99 x | 2.16 x | 4.36 x | 5.48 x | 0.54 x |
| EV / EBITDA | -2.62 x | -3.87 x | -14.4 x | -2.17 x | -0.56 x | -2.45 x | -2.67 x | - |
| EV / FCF | -3.7 x | -5.5 x | -8.66 x | -2.15 x | -0.63 x | -1.83 x | -3.49 x | -0.6 x |
| FCF Yield | -27% | -18.2% | -11.6% | -46.4% | -159% | -54.5% | -28.7% | -167% |
| Price to Book | 1.52 x | 2.36 x | 4.56 x | 1.69 x | - | - | - | - |
| Nbr of stocks (in thousands) | 42,430 | 42,446 | 42,499 | 45,478 | 45,579 | 71,751 | 71,751 | - |
| Reference price 2 | 15.08 | 15.68 | 24.40 | 7.440 | 1.987 | 2.345 | 2.345 | 2.345 |
| Announcement Date | 3/11/19 | 3/4/20 | 3/4/21 | 3/3/22 | 3/8/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 19.08 | 20.65 | 68.46 | 60.69 | 24.5 | 21.51 | 27.32 | 81.02 |
| EBITDA 1 | -90.99 | -104.3 | -62.79 | -111.4 | -93.88 | -38.18 | -56.01 | - |
| EBIT 1 | -93.57 | -111 | -70.94 | -118.2 | -104.9 | -79.36 | -75.44 | -54.63 |
| Operating Margin | -490.35% | -537.42% | -103.62% | -194.83% | -428.31% | -369% | -276.15% | -67.43% |
| Earnings before Tax (EBT) 1 | -78.65 | -103.5 | -80.94 | -113.2 | -107.9 | -71.05 | -76.33 | -64.95 |
| Net income 1 | -70.07 | -91.7 | -67.32 | -103.3 | -100.5 | -69.52 | -69.24 | -62.73 |
| Net margin | -367.18% | -444.07% | -98.32% | -170.26% | -410.1% | -323.23% | -253.48% | -77.43% |
| EPS | -1.710 | -2.165 | -1.586 | -2.308 | -2.205 | - | - | - |
| Free Cash Flow 1 | -64.54 | -73.36 | -104.6 | -112.5 | -83.85 | -51.1 | -42.86 | -72.76 |
| FCF margin | -338.2% | -355.25% | -152.75% | -185.31% | -342.31% | -237.58% | -156.89% | -89.81% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/11/19 | 3/4/20 | 3/4/21 | 3/3/22 | 3/8/23 | - | - | - |
1EUR in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 12.34 | 9.376 | 12.36 | 3.68 | 2.703 | 1.968 | 16.44 | 3.234 | 1.828 | 1.531 | 14.79 | 3.102 | 3.102 | 6.995 | 7 |
| EBITDA 1 | - | - | - | - | - | - | - | - | - | - | 23.49 | -21.48 | -23.96 | -7.22 | - |
| EBIT 1 | -31.65 | -36.69 | -27.98 | -33.85 | -33.31 | -33.98 | -7.92 | -21.29 | -21.61 | -19.24 | -14.36 | -21.19 | -22.04 | -17.89 | -18.97 |
| Operating Margin | -256.46% | -391.32% | -226.32% | -919.81% | -1,232.44% | -1,726.29% | -48.19% | -658.36% | -1,182.36% | -1,257.36% | -97.06% | -683.21% | -710.65% | -255.75% | -271% |
| Earnings before Tax (EBT) 1 | -35.14 | -34.7 | -25.41 | -33.38 | -19.02 | -32.03 | -26.95 | -29.56 | -12.41 | -16.18 | -17.87 | -20.29 | -20.33 | -22.47 | -18.97 |
| Net income 1 | -33.71 | -32.4 | -22.62 | -30.64 | -18.52 | -29.17 | -25.38 | -27.33 | -9.725 | -16.28 | -14.39 | -16.34 | -16.34 | -19.14 | -19.14 |
| Net margin | -273.14% | -345.55% | -182.95% | -832.75% | -685.24% | -1,481.88% | -154.43% | -845.01% | -532.13% | -1,063.38% | -97.27% | -526.69% | -526.69% | -273.59% | -273.39% |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/5/21 | 11/4/21 | 3/3/22 | 5/12/22 | 8/4/22 | 11/3/22 | 3/8/23 | 5/4/23 | 8/3/23 | 11/6/23 | - | - | - | - | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 401 | 262 | 132 | 96.2 | 37.8 | 74.5 | 18.7 | 125 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -64.5 | -73.4 | -105 | -112 | -83.9 | -51.1 | -42.9 | -72.8 |
| ROE (net income / shareholders' equity) | -23.3% | -28.2% | -27.5% | -45.2% | -62.6% | -17.6% | -12.7% | 3.95% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | 9.910 | 6.630 | 5.350 | 4.400 | - | - | - | - |
| Cash Flow per Share | -1.470 | -1.460 | -1.570 | - | - | - | - | - |
| Capex 1 | 4.18 | 11.5 | 37.9 | 17.9 | 2.27 | 0.95 | 0.85 | 0.89 |
| Capex / Sales | 21.89% | 55.91% | 55.42% | 29.42% | 9.26% | 4.42% | 3.13% | 1.09% |
| Announcement Date | 3/11/19 | 3/4/20 | 3/4/21 | 3/3/22 | 3/8/23 | - | - | - |
1EUR in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.16% | 180M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- ALCLS Stock
- Financials Cellectis S.A.
